Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA.
J Matern Fetal Neonatal Med. 2022 Dec;35(25):8492-8497. doi: 10.1080/14767058.2021.1984424. Epub 2021 Oct 6.
Reproductive aged women with fibroids must weigh the risks and benefits of preconception myomectomy. Women with fibroids may have higher rates of fetal growth restriction (FGR) and stillbirth; however, there is a paucity of data on the impact of myomectomy on pregnancy outcomes. We compared perinatal outcomes in women with prior myomectomy versus those with no prior myomectomy and at least one fibroid ≥ 5 cm.
Retrospective cohort study of women at a single center who delivered between 2008 and 2017 with a viable intrauterine pregnancy at initial ultrasound scan and either prior myomectomy, or, in the no-myomectomy cohort, at least one fibroid ≥ 5 cm on a prenatal scan performed at < 21 weeks' gestation (wga). Pregnancies complicated by major congenital anomalies were excluded. Primary outcome was preterm birth (PTB) < 37wga. Secondary outcomes included rates of spontaneous loss, cesarean delivery (CD), abnormal placentation, malpresentation, FGR, birthweight, birthweight percentile, estimated blood loss (EBL), blood transfusion, and neonatal survival to discharge.
A total of 290 women met inclusion criteria: 70 had a prior myomectomy, 220 women had ≥1 fibroid ≥5cm. Women with prior myomectomy were older, more likely to have private insurance, and more likely used artificial reproductive technology to conceive; 20% with prior myomectomy still had at least one ≥ 5 cm myoma on their obstetric scan. Rates of spontaneous loss were lower in the prior myomectomy group (1.4% vs 7.3%; = .08). Of the 273 pregnancies continuing beyond 20 weeks, women with prior myomectomy had significantly more PTBs (35% vs. 21%, = .02) and significantly different primary birth indications ( < .0001). However, after controlling for late preterm, prelabor cesareans recommended by providers in the myomectomy cohort, the difference in PTB rates was not significant ( = .13). The myomectomy group had more CDs (88% vs. 53%, < .0001), higher EBL (1250 mL vs. 811 mL, = .04), and a trend toward more blood transfusions (16% vs 8%, = .05). Other selected outcomes were similar, including rates of FGR.
Women with prior myomectomy had significantly more PTBs, due in part to more preterm, prelabor cesareans in the late preterm period. Otherwise, prior myomectomy did not confer appreciable obstetric or perinatal benefits, as patients had more CDs, and higher EBL. Recommendations to perform preterm prelabor cesareans in this population may explain some of the PTB disparity. The effect of prior myomectomy on early pregnancy loss and infertility requires further study.
患有肌瘤的育龄妇女必须权衡孕前肌瘤切除术的风险和益处。患有肌瘤的妇女胎儿生长受限(FGR)和死胎的发生率可能更高;然而,关于肌瘤切除术对妊娠结局的影响的数据很少。我们比较了有既往肌瘤切除术和无既往肌瘤切除术且至少有一个≥5cm 的肌瘤的妇女的围产期结局。
这是一项对单中心 2008 年至 2017 年期间在初始超声检查时具有存活宫内妊娠且至少有一个≥5cm 的肌瘤的妇女进行的回顾性队列研究。在<21 孕周进行的产前扫描(wga)上进行了子宫肌瘤切除术,或在无子宫肌瘤切除术队列中,至少有一个≥5cm 的肌瘤。排除主要先天性畸形合并妊娠。主要结局是早产(PTB)<37wga。次要结局包括自发流产、剖宫产(CD)、胎盘异常、胎位不正、胎儿生长受限(FGR)、出生体重、出生体重百分位、估计失血量(EBL)、输血和新生儿存活至出院。
共有 290 名妇女符合纳入标准:70 名妇女有既往肌瘤切除术,220 名妇女有≥1 个≥5cm 的肌瘤。有既往肌瘤切除术的妇女年龄较大,更可能有私人保险,更可能使用辅助生殖技术受孕;20%有既往肌瘤切除术的妇女在产科超声检查中仍有至少一个≥5cm 的肌瘤。既往肌瘤切除术组的自发流产率较低(1.4%比 7.3%;=0.08)。在 273 例妊娠持续至 20 周以上的妇女中,有既往肌瘤切除术的妇女早产(35%比 21%,=0.02)和主要分娩指征明显不同(<0.0001)。然而,在控制晚期早产和提供者推荐的产前剖宫产术后,PTB 率的差异无统计学意义(=0.13)。肌瘤切除术组的 CD 更多(88%比 53%,<0.0001),EBL 更高(1250mL 比 811mL,=0.04),输血的趋势更高(16%比 8%,=0.05)。其他选定的结局相似,包括 FGR 发生率。
有既往肌瘤切除术的妇女早产率显著升高,部分原因是在晚期早产期间进行了更多的早产、产前剖宫产术。否则,既往肌瘤切除术并未带来明显的产科或围产期益处,因为患者的 CD 更多,EBL 更高。对该人群进行早产前剖宫产术的建议可能解释了部分 PTB 差异。既往肌瘤切除术对早期妊娠丢失和不孕的影响需要进一步研究。